BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11232948)

  • 1. Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).
    Pandya KJ; Yeap BY; Weiner LM; Krook JE; Erban JK; Schinella RA; Davis TE
    Am J Clin Oncol; 2001 Feb; 24(1):43-6. PubMed ID: 11232948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
    Fleming GF; Filiaci VL; Marzullo B; Zaino RJ; Davidson SA; Pearl M; Makker V; Burke JJ; Zweizig SL; Van Le L; Hanjani P; Downey G; Walker JL; Reyes HD; Leslie KK
    Gynecol Oncol; 2014 Mar; 132(3):585-92. PubMed ID: 24456823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Fiorica JV; Brunetto VL; Hanjani P; Lentz SS; Mannel R; Andersen W;
    Gynecol Oncol; 2004 Jan; 92(1):10-4. PubMed ID: 14751131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Whitney CW; Brunetto VL; Zaino RJ; Lentz SS; Sorosky J; Armstrong DK; Lee RB;
    Gynecol Oncol; 2004 Jan; 92(1):4-9. PubMed ID: 14751130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Lentz SS; Brady MF; Major FJ; Reid GC; Soper JT
    J Clin Oncol; 1996 Feb; 14(2):357-61. PubMed ID: 8636744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
    Crawford DJ; George WD; Smith DC; Stewart M; Paul J; Leake RE
    Oncology; 1994 Oct; 51 Suppl 1():13-8. PubMed ID: 7970503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?
    Herzog TJ
    Gynecol Oncol; 2004 Jan; 92(1):1-3. PubMed ID: 14751129
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen, megestrol acetate, and beta interferon in endometrial cancer.
    Cardone A; Tolino A; Di Serio C; Borruto Caracciolo G; Caccavale C
    Eur J Gynaecol Oncol; 1995; 16(6):500-5. PubMed ID: 8536766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
    Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
    Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
    Pautier P; Vergote I; Joly F; Melichar B; Kutarska E; Hall G; Lisyanskaya A; Reed N; Oaknin A; Ostapenko V; Zvirbule Z; Chetaille E; Geniaux A; Shoaib M; Green JA
    Int J Gynecol Cancer; 2017 Feb; 27(2):258-266. PubMed ID: 27870712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
    Brufman G; Isacson R; Haim N; Gez E; Sulkes A
    Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
    Pinelli DM; Fiorica JV; Roberts WS; Hoffman MS; Nicosia SV; Cavanagh D
    Gynecol Oncol; 1996 Mar; 60(3):462-7. PubMed ID: 8774658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progressive metastatic breast carcinoma.
    Logmans A; Mous HV; Bontenbal M; Beerman H; van Lent M
    Eur J Obstet Gynecol Reprod Biol; 1994 Sep; 56(3):173-6. PubMed ID: 7821489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with paclitaxel, carboplatin and megestrol acetate for the management of advanced stage or recurrent carcinoma of the endometrium: a phase II study.
    Bevis KS; Kilgore LC; Alvarez RD; Straughn JM; Leath CA
    J Reprod Med; 2014; 59(3-4):113-20. PubMed ID: 24724218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide.
    Horton J; Knuiman M; Keller AM; Vogel H; Gale KE; Hahn RG; Rosenbluth RJ; Tormey DC
    Cancer; 1987 Nov; 60(9):2137-40. PubMed ID: 3440224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
    Thigpen T; Brady MF; Homesley HD; Soper JT; Bell J
    J Clin Oncol; 2001 Jan; 19(2):364-7. PubMed ID: 11208827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
    Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial.
    Russell CA; Green SJ; O'Sullivan J; Hynes HE; Budd GT; Congdon JE; Martino S; Osborne CK
    J Clin Oncol; 1997 Jul; 15(7):2494-501. PubMed ID: 9215817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
    Wang CB; Wang CJ; Huang HJ; Hsueh S; Chou HH; Soong YK; Lai CH
    Cancer; 2002 Apr; 94(8):2192-8. PubMed ID: 12001117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.